Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Latest filing published 21 May 2025 for Treace Medical Concepts, INC.. Read the official filing
Filing timeline
BuySaleJane E. Kiernan
Insider track record
Disclosed buys
1
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Jane E. Kiernan: trading record in brief
Jane E. Kiernan (board member) discloses dealings in 2 companies, chiefly Axonics, Inc. and Treace Medical Concepts, Inc. We count 11 filings; the first trade dates from 5 August 2021 and the latest from 20 May 2025.
Market trades split into 1 purchase (€92k) and 1 sale (€189k). Taken together, the sales exceed the purchases by €97k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 7 share grants and 1 option exercise.
On 21 May 2025 came the latest disclosure, a share grant in Treace Medical Concepts, Inc. The last insider purchase was made public on 14 May 2024, 887 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jane E. Kiernan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
23,917 shares0Common StockSEC:0000950170-25-075891:0
19,861 shares@ US$71.0078.5% of flowCommon StockSEC:0001562180-24-007712:0
15,091 shares0Common StockSEC:0000950170-24-063616:0
19,356 shares@ US$5.1664100.0% of flowCommon StockSEC:0000950170-24-059856:0
Canonical exit: 12 Aug 2024 (T+90)
3,000 shares0Common StockSEC:0001562180-23-005533:0
2,753 shares0Common StockSEC:0001209191-23-032350:0
2,832 shares0Common StockSEC:0001209191-22-052526:0
2,100 shares0Common StockSEC:0001562180-22-006265:0
10,000 shares@ US$21.0410.4% of flowCommon StockSEC:0001562180-22-005626:0
3,500 shares@ US$60.0011.1% of flowCommon StockSEC:0001562180-22-003044:0
2,261 shares0Common StockSEC:0001562180-21-006776:0
11 of 11 declarations
